Literature DB >> 17516412

Use of peripheral blood DNA for genotype antiretroviral resistance testing in drug-naive HIV-infected subjects.

Ilaria Vicenti1, Francesca Razzolini, Francesco Saladini, Laura Romano, Maurizio Zazzi.   

Abstract

Parallel analysis of peripheral blood mononuclear cell DNA and plasma RNA from 169 drug-naive human immunodeficiency virus-infected subjects revealed that evaluation of both compartments increases the sensitivity of detection of drug resistance-related mutations, compared with examination of either source alone. Peripheral blood mononuclear cell DNA may play a role in the surveillance of transmitted antiretroviral resistance.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17516412     DOI： 10.1086/518287

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  5 in total

1.  Comparing Peripheral Blood Mononuclear Cell DNA and Circulating Plasma viral RNA pol Genotypes of Subtype C HIV-1.

Authors:  Lauren Banks; Sharareh Gholamin; Elizabeth White; Lynn Zijenah; David A Katzenstein
Journal:  J AIDS Clin Res       Date:  2012-02

2.  Pyrosequencing dried blood spots reveals differences in HIV drug resistance between treatment naïve and experienced patients.

Authors:  Hezhao Ji; Yang Li; Binhua Liang; Richard Pilon; Paul MacPherson; Michèle Bergeron; John Kim; Morag Graham; Gary Van Domselaar; Paul Sandstrom; James Brooks
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

3.  Deep Sequencing of HIV-1 RNA and DNA in Newly Diagnosed Patients with Baseline Drug Resistance Showed No Indications for Hidden Resistance and Is Biased by Strong Interference of Hypermutation.

Authors:  Kenny Dauwe; Delfien Staelens; Leen Vancoillie; Virginie Mortier; Chris Verhofstede
Journal:  J Clin Microbiol       Date:  2016-04-13       Impact factor: 5.948

4.  Drug resistance mutations and viral load in human immunodeficiency virus type 2 and dual HIV-1/HIV-2 infected patients in Ghana.

Authors:  Christopher Z Abana; Kwamena W C Sagoe; Evelyn Y Bonney; Edward K Maina; Ishmael D Aziati; Esinam Agbosu; Gifty Mawuli; Linda M Styer; Koichi Ishikawa; James A M Brandful; William K Ampofo
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

5.  HIV-1C proviral DNA for detection of drug resistance mutations.

Authors:  Kahsay Huruy; Andargachew Mulu; Uwe Gerd Liebert; Melanie Maier
Journal:  PLoS One       Date:  2018-10-04       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.